These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3907935)

  • 1. Nomifensine maleate: a new second-generation antidepressant.
    Kinney JL
    Clin Pharm; 1985; 4(6):625-36. PubMed ID: 3907935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant properties of trazodone.
    Bryant SG; Ereshefsky L
    Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of bupropion.
    Bryant SG; Guernsey BG; Ingrim NB
    Clin Pharm; 1983; 2(6):525-37. PubMed ID: 6140095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomifensine maleate (Merital, Hoechst-Roussel).
    Fields ED
    Drug Intell Clin Pharm; 1982; 16(7-8):547-52. PubMed ID: 7049645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of amoxapine.
    Kinney JL; Evans RL
    Clin Pharm; 1982; 1(5):417-24. PubMed ID: 6764165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the clinical safety and tolerability of nomifensine.
    Stonier PD
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):89-95. PubMed ID: 6370984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical trial of nomifensine in treatment of depression (author's transl)].
    Zaccara G; Ferrara M; Ardito P
    Riv Patol Nerv Ment; 1979; 100(3):111-20. PubMed ID: 400045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of nomifensine: a review of animal studies.
    Fielding S; Szewczak MR
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):12-20. PubMed ID: 6370970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of nomifensine in the treatment of depressive states (author's transl)].
    Zermatten A; Cumps J
    Acta Psychiatr Belg; 1981; 81(4):379-98. PubMed ID: 7036657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to five new antidepressants.
    Hayes PE; Kristoff CA
    Clin Pharm; 1986 Jun; 5(6):471-80. PubMed ID: 3087684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of the efficacy and safety of nomifensine maleate vs. placebo in depressed outpatients.
    Georgia EH
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):43-6. PubMed ID: 6232263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second generation antidepressants.
    Shopsin B
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):45-56. PubMed ID: 6969258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.